Skip to content
2000
image of Personalized Nanocomposite-based Drug Delivery Systems: Integration of AI and 3D Printing

Abstract

Introduction

This review aims to comprehensively discuss the emerging role of artificial intelligence (AI) and three-dimensional (3D) printing in the design and development of personalized polymeric nanocomposite-based drug delivery systems. The focus is on how integrating these technologies enhances the precision, efficacy, and customization of pharmacotherapy compared with conventional formulations.

Methods

An extensive literature survey was conducted using databases such as PubMed, Scopus, Web of Science, and ScienceDirect, focusing on publications from the past decade. Peer-reviewed studies, reviews, and reports on polymeric nanocomposites, AI-based formulation design, and 3D-printed drug delivery systems were critically analyzed. The collected data were synthesized to elucidate design principles, fabrication methods, and the synergistic application of AI and 3D printing in personalized medicine.

Results

Polymeric nanocomposites have demonstrated superior performance in targeted and controlled drug release due to their adaptable physicochemical properties and biocompatibility. The application of AI enables predictive modeling, optimization of formulation parameters, and patient stratification through data-driven algorithms. Concurrently, 3D printing enables the fabrication of patient-specific dosage forms and implants with programmable drug-release profiles. Together, these technologies enable the development of individualized therapeutic systems that enhance treatment outcomes and minimize adverse effects.

Discussion

This synergistic incorporation of AI and additive manufacturing tackles some of the main obstacles in precision medicine by diminishing trial-and-error in formulation, enhancing reproducibility, and promoting better outcomes during treatment. Such multidisciplinary applications are most promising in cancer, diabetes, neurodegenerative, infectious, and cardiovascular diseases.

Conclusion

The integration of AI and 3D printing represents a transformative advancement in personalized nanocomposite drug delivery. These interdisciplinary approaches collectively enable precise control over drug release kinetics, dosage customization, and formulation design. Future developments focusing on regulatory standardization, ethical data use, and large-scale clinical translation will further accelerate the adoption of AI- and 3D-printing-assisted personalized drug delivery systems in clinical practice. While these technologies hold great potential for personalized and precise therapeutics, their clinical translation remains challenged by regulatory validation, manufacturing reproducibility, and data transparency requirements.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdt/10.2174/0113894501430905251210054617
2026-01-19
2026-03-02

  • From This Site

    /content/journals/cdt/10.2174/0113894501430905251210054617
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Idumah C.I. Recent advancements in self-healing polymers, polymer blends, and nanocomposites. Polym. Polymer Compos. 2021 29 4 246 258 10.1177/0967391120910882
    [Google Scholar]
  2. Fong M.K. Rahman M.N.A. Arifin A.M.T. Haq R.H.A. Hassan M.F. Taib I. Characterization, thermal and biological properties of PCL/PLA/PEG/N-HA composites. Biointerface Res. Appl. Chem. 2021 11 2 9017 9026 10.33263/BRIAC112.90179026
    [Google Scholar]
  3. Boruah J. Chowdhury D. Advances in carbon nanomaterial–clay nanocomposites for diverse applications. Minerals 2022 13 1 26 10.3390/min13010026
    [Google Scholar]
  4. Sri Abirami Saraswathi M.S. Nagendran A. Rana D. Tailored polymer nanocomposite membranes based on carbon, metal oxide and silicon nanomaterials: A review. J. Mater. Chem. A Mater. Energy Sustain. 2019 7 15 8723 8745 10.1039/C8TA11460A
    [Google Scholar]
  5. Viswanathan P. Muralidaran Y. Ragavan G. Challenges in oral drug delivery: A nano-based strategy to overcom. Nanostructures for oral medicine. Elsevier 2017 173 201 10.1016/B978‑0‑323‑47720‑8.00008‑0
    [Google Scholar]
  6. Shetab Boushehri M. Dietrich D. Lamprecht A. Nanotechnology as a platform for the development of injectable parenteral formulations: A comprehensive review of the know-hows and state of the art. Pharmaceutics 2020 12 6 510 10.3390/pharmaceutics12060510 32503171
    [Google Scholar]
  7. Kroschinsky F. Stölzel F. von Bonin S. New drugs, new toxicities: Severe side effects of modern targeted and immunotherapy of cancer and their management. Crit. Care 2017 21 1 89 10.1186/s13054‑017‑1678‑1 28407743
    [Google Scholar]
  8. Park H. Otte A. Park K. Evolution of drug delivery systems: From 1950 to 2020 and beyond. J. Control. Release 2022 342 53 65 10.1016/j.jconrel.2021.12.030 34971694
    [Google Scholar]
  9. Shrank W.H. Hoang T. Ettner S.L. The implications of choice: Prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions. Arch. Intern. Med. 2006 166 3 332 337 10.1001/archinte.166.3.332 16476874
    [Google Scholar]
  10. Sandler N. Preis M. Printed drug-delivery systems for improved patient treatment. Trends Pharmacol. Sci. 2016 37 12 1070 1080 10.1016/j.tips.2016.10.002 27992318
    [Google Scholar]
  11. Elsabahy M. Heo G.S. Lim S.M. Sun G. Wooley K.L. Polymeric nanostructures for imaging and therapy. Chem. Rev. 2015 115 19 10967 11011 10.1021/acs.chemrev.5b00135 26463640
    [Google Scholar]
  12. Verma D. Dong Y. Sharma M. Chaudhary A.K. Advanced processing of 3D printed biocomposite materials using artificial intelligence. Mater. Manuf. Process. 2022 37 5 518 538 10.1080/10426914.2021.1945090
    [Google Scholar]
  13. Gupta R. Srivastava D. Sahu M. Tiwari S. Ambasta R.K. Kumar P. Artificial intelligence to deep learning: Machine intelligence approach for drug discovery. Mol. Divers. 2021 25 3 1315 1360 10.1007/s11030‑021‑10217‑3 33844136
    [Google Scholar]
  14. Nicolaou K.C. Advancing the drug discovery and development process. Angew. Chem. Int. Ed. 2014 53 35 9128 9140 10.1002/anie.201404761 25045053
    [Google Scholar]
  15. Wang J. Zhang Y. Aghda N.H. Emerging 3D printing technologies for drug delivery devices: Current status and future perspective. Adv. Drug Deliv. Rev. 2021 174 294 316 10.1016/j.addr.2021.04.019 33895212
    [Google Scholar]
  16. Robles-Martinez P. Xu X. Trenfield S.J. 3D printing of a multi-layered polypill containing six drugs using a novel stereolithographic method. Pharmaceutics 2019 11 6 274 10.3390/pharmaceutics11060274 31212649
    [Google Scholar]
  17. Li Y. Sun K. Shao Y. Next-generation approaches for biomedical materials evaluation: microfluidics and organ-on-a-chip technologies. Adv. Healthc. Mater. 2025 14 1 2402611 10.1002/adhm.202402611 39440635
    [Google Scholar]
  18. Njuguna J. Ansari F. Sachse S. Rodriguez V.M. Siqqique S. Zhu H. Nanomaterials, nanofillers, and nanocomposites: Types and properties. Health and environmental safety of nanomaterials. Woodhead Publishing 2021 3 37 10.1533/9780857096678.1.3
    [Google Scholar]
  19. Miñano J. Puiggalí J. Franco L. Effect of curcumin on thermal degradation of poly(glycolic acid) and poly(ε-caprolactone) blends. Thermochim. Acta 2020 693 178764 10.1016/j.tca.2020.178764
    [Google Scholar]
  20. Germershaus O. Lühmann T. Rybak J.C. Ritzer J. Meinel L. Application of natural and semi-synthetic polymers for the delivery of sensitive drugs. Int. Mater. Rev. 2015 60 2 101 131 10.1179/1743280414Y.0000000045
    [Google Scholar]
  21. Naga Mallikarjun Rao G. Vakkalagadda M.R.K. A review on synthesis, characterization and applications of nanoparticles in polymer nanocomposites. Mater. Today Proc. 2024 98 68 80 10.1016/j.matpr.2023.09.135
    [Google Scholar]
  22. Thirugnanasambandan T. Polymers-metal nanocomposites. In: Environmental Nanotechnology. Cham: Springer 2018 2 213 254 10.1007/978‑3‑319‑98708‑8_8
    [Google Scholar]
  23. Wang H. Cao G. Gai Z. Hong K. Banerjee P. Zhou S. Magnetic/NIR-responsive drug carrier, multicolor cell imaging, and enhanced photothermal therapy of gold capped magnetite-fluorescent carbon hybrid nanoparticles. Nanoscale 2015 7 17 7885 7895 10.1039/C4NR07335E 25854197
    [Google Scholar]
  24. Vrignaud S. Benoit J.P. Saulnier P. Strategies for the nanoencapsulation of hydrophilic molecules in polymer-based nanoparticles. Biomaterials 2011 32 33 8593 8604 10.1016/j.biomaterials.2011.07.057 21831421
    [Google Scholar]
  25. Gao C. Zhang L. Wang J. Electrospun nanofibers promote wound healing: Theories, techniques, and perspectives. J. Mater. Chem. B Mater. Biol. Med. 2021 9 14 3106 3130 10.1039/D1TB00067E 33885618
    [Google Scholar]
  26. Jonker A.M. Löwik D.W.P.M. van Hest J.C.M. Peptide-and protein-based hydrogels. Chem. Mater. 2012 24 5 759 773 10.1021/cm202640w
    [Google Scholar]
  27. Keledi G. Hári J. Pukánszky B. Polymer nanocomposites: Structure, interaction, and functionality. Nanoscale 2012 4 6 1919 1938 10.1039/c2nr11442a 22349033
    [Google Scholar]
  28. Kouser R. Vashist A. Zafaryab M. Rizvi M.A. Ahmad S. pH-responsive biocompatible nanocomposite hydrogels for therapeutic drug delivery. ACS Appl. Bio Mater. 2018 1 6 1810 1822 10.1021/acsabm.8b00260 34996282
    [Google Scholar]
  29. Swietach P. Vaughan-Jones R.D. Harris A.L. Hulikova A. The chemistry, physiology and pathology of pH in cancer. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2014 369 1638 20130099 10.1098/rstb.2013.0099 24493747
    [Google Scholar]
  30. Kamaly N. Yameen B. Wu J. Farokhzad O.C. Degradable controlled-release polymers and polymeric nanoparticles: Mechanisms of controlling drug release. Chem. Rev. 2016 116 4 2602 2663 10.1021/acs.chemrev.5b00346 26854975
    [Google Scholar]
  31. Balamurali V. Pramodkuma T.M. Srujana N. pH sensitive drug delivery systems: A review. Am J Drug Discov Dev 2010 1 1 24 48 10.3923/ajdd.2011.24.48
    [Google Scholar]
  32. Seth A.K. Parmar G. Aundhia C. Shah N. Gohil D. Smart polymer systems: A futuristic approach to enhance therapeutic efficacy. Curr. Org. Chem. 2024 28 15 1164 1178 10.2174/0113852728305580240429100851
    [Google Scholar]
  33. Cheng R. Feng F. Meng F. Deng C. Feijen J. Zhong Z. Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery. J. Control. Release 2011 152 1 2 12 10.1016/j.jconrel.2011.01.030 21295087
    [Google Scholar]
  34. Mukherjee A. Das B. The role of inflammatory mediators and matrix metalloproteinases (MMPs) in the progression of osteoarthritis. Biomater. Biosyst. 2024 13 100090 10.1016/j.bbiosy.2024.100090 38440290
    [Google Scholar]
  35. Wu J. The enhanced permeability and retention (EPR) effect: The significance of the concept and methods to enhance its application. J. Pers. Med. 2021 11 8 771 10.3390/jpm11080771 34442415
    [Google Scholar]
  36. Kobayashi H. Watanabe R. Choyke P.L. Improving conventional enhanced permeability and retention (EPR) effects; what is the appropriate target? Theranostics 2014 4 1 81 89 10.7150/thno.7193 24396516
    [Google Scholar]
  37. Kunjiappan S. Pavadai P. Vellaichamy S. Surface receptor-mediated targeted drug delivery systems for enhanced cancer treatment: A state-of-the-art review. Drug Dev. Res. 2021 82 3 309 340 10.1002/ddr.21758 33170541
    [Google Scholar]
  38. Castel S. Pagan R. Mitjans F. RGD peptides and monoclonal antibodies, antagonists of α(v)-integrin, enter the cells by independent endocytic pathways. Lab. Invest. 2001 81 12 1615 1626 10.1038/labinvest.3780375 11742032
    [Google Scholar]
  39. Zhi D. Yang T. Yang J. Fu S. Zhang S. Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy. Acta Biomater. 2020 102 13 34 10.1016/j.actbio.2019.11.027 31759124
    [Google Scholar]
  40. Aundhia C. Parmar G. Talele C. kardani S, Maheshwari R. Light-responsive polymers: Developments in drug delivery systems. Curr. Org. Chem. 2024 28 15 1179 1189 10.2174/0113852728307241240430055059
    [Google Scholar]
  41. Yaramiri A. Asalh R.A. Asalh M.A. AlSawaftah N. Abuwatfa W.H. Husseini G.A. A comprehensive review of smart thermosensitive nanocarriers for precision cancer therapy. Int. J. Mol. Sci. 2025 26 15 7322 10.3390/ijms26157322 40806454
    [Google Scholar]
  42. Maier-Hauff K. Rothe R. Scholz R. Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: Results of a feasibility study on patients with glioblastoma multiforme. J. Neurooncol. 2007 81 1 53 60 10.1007/s11060‑006‑9195‑0 16773216
    [Google Scholar]
  43. Schwake M. Müther M. Bruns A.K. Combined fluorescence-guided resection and intracavitary thermotherapy with superparamagnetic iron-oxide nanoparticles for recurrent high-grade glioma: Case series with emphasis on complication management. Cancers 2022 14 3 541 10.3390/cancers14030541 35158809
    [Google Scholar]
  44. Zhang Z. Wang J. Nie X. Near infrared laser-induced targeted cancer therapy using thermoresponsive polymer encapsulated gold nanorods. J. Am. Chem. Soc. 2014 136 20 7317 7326 10.1021/ja412735p 24773323
    [Google Scholar]
  45. Chakravarthi M.K. Kumar Y.V.P. Reddy G.P. Potential technological advancements in the future of process control and automation. 2024 IEEE Open Conference of Electrical, Electronic and Information Sciences Vilnius, Lithuania, 25-25 April 2024 1 6 10.1109/eStream61684.2024.10542581
    [Google Scholar]
  46. Bhakay A. Rahman M. Dave R.N. Bilgili E. Bioavailability enhancement of poorly water-soluble drugs via nanocomposites: Formulation–Processing aspects and challenges. Pharmaceutics 2018 10 3 86 10.3390/pharmaceutics10030086 29986543
    [Google Scholar]
  47. Procopio A. Lagreca E. Jamaledin R. Recent fabrication methods to produce polymer-based drug delivery matrices (experimental and in silico approaches). Pharmaceutics 2022 14 4 872 10.3390/pharmaceutics14040872 35456704
    [Google Scholar]
  48. Liu Y. Yang G. Zou D. Formulation of nanoparticles using mixing-induced nanoprecipitation for drug delivery. Ind. Eng. Chem. Res. 2020 59 9 4134 4149 10.1021/acs.iecr.9b04747
    [Google Scholar]
  49. Chaudhary S.A. Patel D.M. Patel J.K. Patel D.H. Solvent emulsification evaporation and solvent emulsification diffusion techniques for nanoparticles. Emerging technologies for nanoparticle manufacturing. Cham Springer 2021 287 300 10.1007/978‑3‑030‑50703‑9_12
    [Google Scholar]
  50. Srivastava A. Yadav T. Sharma S. Nayak A. Akanksha Kumari A. Mishra N. Polymers in drug delivery. J. Biosci. Med. 2016 4 1 69 84 10.4236/jbm.2016.41009
    [Google Scholar]
  51. Sacco P. Pedroso-Santana S. Kumar Y. Joly N. Martin P. Bocchetta P. Ionotropic gelation of chitosan flat structures and potential applications. Molecules 2021 26 3 660 10.3390/molecules26030660 33513925
    [Google Scholar]
  52. Tang S. Yang J. Lin L. Construction of physically crosslinked chitosan/sodium alginate/calcium ion double-network hydrogel and its application to heavy metal ions removal. Chem. Eng. J. 2020 393 124728 10.1016/j.cej.2020.124728
    [Google Scholar]
  53. Liu R. Hou L. Yue G. Progress of fabrication and applications of electrospun hierarchically porous nanofibers. Adv. Fiber Mater. 2022 4 4 604 630 10.1007/s42765‑022‑00132‑z
    [Google Scholar]
  54. Wang Y. Kho K. Cheow W.S. Hadinoto K. A comparison between spray drying and spray freeze drying for dry powder inhaler formulation of drug-loaded lipid–polymer hybrid nanoparticles. Int. J. Pharm. 2012 424 1-2 98 106 10.1016/j.ijpharm.2011.12.045 22226876
    [Google Scholar]
  55. Liu Z. Fontana F. Python A. Hirvonen J.T. Santos H.A. Microfluidics for production of particles: Mechanism, methodology, and applications. Small 2020 16 9 1904673 10.1002/smll.201904673 31702878
    [Google Scholar]
  56. Kannayiram G. Sendilvelan S. R MP. Importance of nanocomposites in 3D bioprinting: An overview. Bioprinting 2023 32 e00280 10.1016/j.bprint.2023.e00280
    [Google Scholar]
  57. Massey M. Algar W.R. Nanoparticle bioconjugates: Materials that benefit from chemoselective and bioorthogonal ligation chemistries. Chemoselective and bioorthogonal ligation reactions: Concepts and applications. Wiley 2017 543 629 10.1002/9783527683451.ch17
    [Google Scholar]
  58. Kiss A.L. Botos E. Endocytosis via caveolae: Alternative pathway with distinct cellular compartments to avoid lysosomal degradation? J. Cell. Mol. Med. 2009 13 7 1228 1237 10.1111/j.1582‑4934.2009.00754.x 19382909
    [Google Scholar]
  59. Pathak C. Vaidya F.U. Waghela B.N. Insights of endocytosis signaling in health and disease. Int. J. Mol. Sci. 2023 24 3 2971 10.3390/ijms24032971 36769293
    [Google Scholar]
  60. Skrzyniarz K. Kuc-Ciepluch D. Lasak M. Arabski M. Sanchez-Nieves J. Ciepluch K. Dendritic systems for bacterial outer membrane disruption as a method of overcoming bacterial multidrug resistance. Biomater. Sci. 2023 11 19 6421 6435 10.1039/D3BM01255G 37605901
    [Google Scholar]
  61. Yıldırım M. Demirkaya D.B. Aydın C. Yalcın S. Cytotoxicity and biocompatibility of bionanomaterials. Bionanomaterials for Industrial Applications. CRC Press 2024 325 346 10.1201/9781003432791‑22
    [Google Scholar]
  62. Kusuma H.S. Al Lantip G.I. Mutiara X. A detail account of natural nanofibers (as chitin/chitosan, cellulose, gelatin, alginate, hyaluronic acid, fibrin, collagen, etc.). Polymeric Nanofibers and their Composites. Elsevier 2025 91 111 10.1016/B978‑0‑443‑14128‑7.00005‑5
    [Google Scholar]
  63. Rezić I. Haramina T. Rezić T. Metal nanoparticles and carbon nanotubes—perfect antimicrobial nano-fillers in polymer-based food packaging materials. Food packaging. Academic Press 2017 497 532 10.1016/B978‑0‑12‑804302‑8.00015‑7
    [Google Scholar]
  64. Mohapatra P. Singh D. Sahoo S.K. PEGylated nanoparticles as a versatile drug delivery system. Nanoengineering of Biomaterials. Wiley 2022 309 341 10.1002/9783527832095.ch10
    [Google Scholar]
  65. Alfei S. Schito A.M. Positively charged polymers as promising devices against multidrug resistant gram-negative bacteria: A Review. Polymers 2020 12 5 1195 10.3390/polym12051195 32456255
    [Google Scholar]
  66. Podgórski R. Wojasiński M. Ciach T. Nanofibrous materials affect the reaction of cytotoxicity assays. Sci. Rep. 2022 12 1 9047 10.1038/s41598‑022‑13002‑w 35641539
    [Google Scholar]
  67. Low Y.J. Andriyana A. Ang B.C. Zainal Abidin N.I. Bioresorbable and degradable behaviors of PGA: Current state and future prospects. Polym. Eng. Sci. 2020 60 11 2657 2675 10.1002/pen.25508
    [Google Scholar]
  68. Katebifar S. Arul M. Abdulmalik S. Yu X. Alderete J.F. Kumbar S.G. Novel high-strength polyester composite scaffolds for bone regeneration. Polym. Adv. Technol. 2023 34 12 3770 3791 10.1002/pat.6178 38312483
    [Google Scholar]
  69. Avgoustakis K. Beletsi A. Panagi Z. Klepetsanis P. Karydas A.G. Ithakissios D.S. PLGA–mPEG nanoparticles of cisplatin: In vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J. Control. Release 2002 79 1-3 123 135 10.1016/S0168‑3659(01)00530‑2 11853924
    [Google Scholar]
  70. Chen Z. Han S. Yang X. Overcoming multiple absorption barrier for insulin oral delivery using multifunctional nanoparticles based on chitosan derivatives and hyaluronic acid. Int. J. Nanomedicine 2020 15 4877 4898 10.2147/IJN.S251627 32753869
    [Google Scholar]
  71. Olariu C.I. Yiu H.H.P. Bouffier L. Inorganic–organic hybrid nanoparticles for medical applications. New Frontiers of Nanoparticles and Nanocomposite Materials: Novel Principles and Techniques. Berlin, Heidelberg Springer 2010 85 133 10.1007/8611_2010_30
    [Google Scholar]
  72. Dawidczyk C.M. Russell L.M. Searson P.C. Nanomedicines for cancer therapy: State-of-the-art and limitations to pre-clinical studies that hinder future developments. Front Chem. 2014 2 69 10.3389/fchem.2014.00069 25202689
    [Google Scholar]
  73. Rahmani A.M. Azhir E. Ali S. Artificial intelligence approaches and mechanisms for big data analytics: A systematic study. PeerJ Comput. Sci. 2021 7 e488 10.7717/peerj‑cs.488 33954253
    [Google Scholar]
  74. Panchpuri M. Painuli R. Kumar C. Artificial intelligence in smart drug delivery systems: A step toward personalized medicine. RSC Pharm 2025 2 5 882 914 10.1039/d5pm00089k
    [Google Scholar]
  75. Tomuta I. Porfire A. Iurian S. Casian T. Optimization techniques in pharmaceutical formulation and processing. Dosage forms, formulation developments and regulations. Academic Press 2024 257 284 10.1016/B978‑0‑323‑91817‑6.00014‑0
    [Google Scholar]
  76. Huwaimel B. Alqarni S. Design of Poly(lactic-co-glycolic acid) nanoparticles in drug delivery by artificial intelligence methods to find the conditions of nanoparticles synthesis. Chemom. Intell. Lab. Syst. 2025 258 105335 10.1016/j.chemolab.2025.105335
    [Google Scholar]
  77. Bhagya Raj G.V.S. Dash K.K. Comprehensive study on applications of artificial neural network in food process modeling. Crit. Rev. Food Sci. Nutr. 2022 62 10 2756 2783 10.1080/10408398.2020.1858398 33327740
    [Google Scholar]
  78. Chauhan B.V.S. Verma S. Rahman B.M.A. Wyche K.P. Deep learning in airborne particulate matter sensing and surface plasmon resonance for environmental monitoring. Atmosphere 2025 16 4 359 10.3390/atmos16040359
    [Google Scholar]
  79. Regenwetter L. Nobari A.H. Ahmed F. Deep generative models in engineering design: A review. J. Mech. Des. 2022 144 7 071704 10.1115/1.4053859
    [Google Scholar]
  80. Luo S. Zhao C. Wang R. Wu D. Sequential drug release nanocomposites for diseases synergistic therapy. J. Mater. Chem. B Mater. Biol. Med. 2025 13 14 4313 4329 10.1039/D5TB00026B
    [Google Scholar]
  81. Sivamayil K. Rajasekar E. Aljafari B. Nikolovski S. Vairavasundaram S. Vairavasundaram I. A systematic study on reinforcement learning based applications. Energies 2023 16 3 1512 10.3390/en16031512
    [Google Scholar]
  82. Steiner S. Wolf J. Glatzel S. Organic synthesis in a modular robotic system driven by a chemical programming language. Science 2019 363 6423 eaav2211 10.1126/science.aav2211 30498165
    [Google Scholar]
  83. Mirakhori F. Niazi S.K. Harnessing the AI/ML in drug and biological products discovery and development: The regulatory perspective. Pharmaceuticals 2025 18 1 47 10.3390/ph18010047 39861110
    [Google Scholar]
  84. Torun H.M. Swaminathan M. Davis A.K. Bellaredj M.L.F. A global Bayesian optimization algorithm and its application to integrated system design. IEEE Trans Very Large Scale Integr (VLSI). Syst 2018 26 4 792 802 10.1109/TVLSI.2017.2784783
    [Google Scholar]
  85. Kumar H. Application of NSGA-II for reliability optimization in pharmaceutical plant design. AIP Conf Proc 2024 3188 100018 10.1063/5.0240717
    [Google Scholar]
  86. Shetty P. Ramprasad R. Automated knowledge extraction from polymer literature using natural language processing. iScience 2021 24 1 101922 10.1016/j.isci.2020.101922 33458607
    [Google Scholar]
  87. Sharma S. From data to decisions: Cloud, IoT, and AI integration. Integration of Cloud Computing and IoT. Chapman and Hall/CRC 2025 461 479
    [Google Scholar]
  88. Youshia J. Ali M.E. Lamprecht A. Artificial neural network based particle size prediction of polymeric nanoparticles. Eur. J. Pharm. Biopharm. 2017 119 333 342 10.1016/j.ejpb.2017.06.030 28694160
    [Google Scholar]
  89. Awad M. Khanna R. Support vector machines for classificationEfficient learning machines: Theories, concepts, and applications for engineers and system designers. Berkeley, CA Apress 2015 39 66 10.1007/978‑1‑4302‑5990‑9_3
    [Google Scholar]
  90. Rajasekhar N. Radhakrishnan T.K. Samsudeen N. Deep deterministic policy gradient reinforcement learning based temperature control of a fermentation bioreactor for ethanol production. J. Indian Chem. Soc. 2025 102 2 101575 10.1016/j.jics.2025.101575
    [Google Scholar]
  91. Vilar S. Friedman C. Hripcsak G. Detection of drug–drug interactions through data mining studies using clinical sources, scientific literature and social media. Brief. Bioinform. 2018 19 5 863 877 10.1093/bib/bbx010 28334070
    [Google Scholar]
  92. Alvarado Maldonado D. Application of deep generative models for the design of pharmaceutical manufacturing processes. Student thesis: Doctoral Thesis 2024
    [Google Scholar]
  93. Feldman D. Polymers and polymer nanocomposites for cancer therapy. Appl. Sci. 2019 9 18 3899 10.3390/app9183899
    [Google Scholar]
  94. Kyriazos T. Poga M. Application of machine learning models in social sciences: Managing nonlinear relationships. Encyclopedia 2024 4 4 1790 1805 10.3390/encyclopedia4040118
    [Google Scholar]
  95. Ahmed S.F. Alam M.S.B. Hassan M. Deep learning modelling techniques: Current progress, applications, advantages, and challenges. Artif. Intell. Rev. 2023 56 11 13521 13617 10.1007/s10462‑023‑10466‑8
    [Google Scholar]
  96. Ghahramani Z. Probabilistic machine learning and artificial intelligence. Nature 2015 521 7553 452 459 10.1038/nature14541 26017444
    [Google Scholar]
  97. Klapa Antonion X.W. Raissi M. Joshie L. Machine learning through physics–informed neural networks: Progress and challenges. Acad J Sci Technol 2024 9 1 2024
    [Google Scholar]
  98. Mai B.T. Fernandes S. Balakrishnan P.B. Pellegrino T. Nanosystems based on magnetic nanoparticles and thermo-or pH-responsive polymers: An update and future perspectives. Acc. Chem. Res. 2018 51 5 999 1013 10.1021/acs.accounts.7b00549 29733199
    [Google Scholar]
  99. Hassan A. Artificial intelligence in multi-omics data integration: Advancing precision medicine, biomarker discovery and genomic-driven disease interventions. Int J Sci Res Arch 2023 8 1 1012 1030 10.30574/ijsra.2023.8.1.0189
    [Google Scholar]
  100. Yang W.C. Lai J.P. Liu Y.H. Lin Y.L. Hou H.P. Pai P.F. Using medical data and clustering techniques for a smart healthcare system. Electronics 2023 13 1 140 10.3390/electronics13010140
    [Google Scholar]
  101. De Carlo A. Reinforcement Learning and PK-PD modelling for precision dosing. Doctoral thesis 2025
    [Google Scholar]
  102. Łukaniszyn M. Majka Ł. Grochowicz B. Mikołajewski D. Kawala-Sterniuk A. Digital twins generated by artificial intelligence in personalized healthcare. Appl. Sci. 2024 14 20 9404 10.3390/app14209404
    [Google Scholar]
  103. Sundaram V. Aryal S. Emerging biomimetic drug delivery nanoparticles inspired by extracellular vesicles. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2025 17 4 e70025 10.1002/wnan.70025 40840553
    [Google Scholar]
  104. Yudaev P. Butorova I. Chuev V. Posokhova V. Klyukin B. Chistyakov E. Wound gel with antimicrobial effects based on polyvinyl alcohol and functional aryloxycyclotriphosphazene. Polymers 2023 15 13 2831 10.3390/polym15132831 37447477
    [Google Scholar]
  105. Beg S. Almalki W.H. Malik A. 3D printing for drug delivery and biomedical applications. Drug Discov. Today 2020 25 9 1668 1681 10.1016/j.drudis.2020.07.007 32687871
    [Google Scholar]
  106. Zhou L. Miller J. Vezza J. Additive manufacturing: A comprehensive review. Sensors 2024 24 9 2668 10.3390/s24092668 38732776
    [Google Scholar]
  107. Kafle A. Luis E. Silwal R. Pan H.M. Shrestha P.L. Bastola A.K. 3D/4D printing of polymers: Fused deposition modelling (FDM), selective laser sintering (SLS), and stereolithography (SLA). Polymers 2021 13 18 3101 10.3390/polym13183101 34578002
    [Google Scholar]
  108. Montez M. Willis K. Rendler H. Marshall C. Rubio E. Rajak D.K. Fused deposition modeling (FDM): Processes, material properties, and applications. Tribology of Additively Manufactured Materials. Elsevier 2022 137 163 10.1016/B978‑0‑12‑821328‑5.00005‑6
    [Google Scholar]
  109. Stella S.M. Sridhar T.M. Ramprasath R. Gimbun J. Vijayalakshmi U. Physio-chemical and biological characterization of novel HPC (hydroxypropylcellulose): HAP (hydroxyapatite): PLA (poly lactic acid) electrospun nanofibers as implantable material for bone regenerative application. Polymers 2022 15 1 155 10.3390/polym15010155 36616505
    [Google Scholar]
  110. Li S. Shan Y. Chen J. 3D printing and biomedical applications of piezoelectric composites: A critical review. Adv. Mater. Technol. 2025 10 5 2401160 10.1002/admt.202401160
    [Google Scholar]
  111. Funk N.L. Leão J. de Oliveira T.V. Beck R.C.R. Semi-solid extrusion (SSE) in pharmaceuticals. Additive Manufacturing in Pharmaceuticals. Singapore Springer 2023 171 200 10.1007/978‑981‑99‑2404‑2_5
    [Google Scholar]
  112. Monaco E. Tailored doses by means of semi-solid extrusion-based 3D printing: A study in pharmaceutical sciences. Thesis 2023
    [Google Scholar]
  113. Pagac M. Hajnys J. Ma Q.P. A review of vat photopolymerization technology: Materials, applications, challenges, and future trends of 3D printing. Polymers 2021 13 4 598 10.3390/polym13040598 33671195
    [Google Scholar]
  114. Hu Y. Luo Z. Bao Y. Trends in photopolymerization 3D printing for advanced drug delivery applications. Biomacromolecules 2025 26 1 85 117 10.1021/acs.biomac.4c01004 39625843
    [Google Scholar]
  115. Yehia H.M. Hamada A. Sebaey T.A. Abd-Elaziem W. Selective laser sintering of polymers: Process parameters, machine learning approaches, and future directions. J Manuf Mater Process 2024 8 5 197 10.3390/jmmp8050197
    [Google Scholar]
  116. Dubey K.A. Chaudhari C.V. Bhardwaj Y.K. Varshney L. Polymers, blends and nanocomposites for implants, scaffolds and controlled drug release applications. Advances in biomaterials for biomedical applications. Singapore Springer 2017 1 44 10.1007/978‑981‑10‑3328‑5_1
    [Google Scholar]
  117. Desu P.K. Maddiboyina B. Vanitha K. Rao Gudhanti S.N.K. Anusha R. Jhawat V. 3D printing technology in pharmaceutical dosage forms: Advantages and challenges. Curr. Drug Targets 2021 22 16 1901 1914 10.2174/1389450122666210120142416 33494666
    [Google Scholar]
  118. Lam C.X.F. Mo X.M. Teoh S.H. Hutmacher D.W. Scaffold development using 3D printing with a starch-based polymer. Mater. Sci. Eng. C 2002 20 1-2 49 56 10.1016/S0928‑4931(02)00012‑7
    [Google Scholar]
  119. Afsana Jain V. Haider N, Jain K. 3D printing in personalized drug delivery. Curr. Pharm. Des. 2019 24 42 5062 5071 10.2174/1381612825666190215122208 30767736
    [Google Scholar]
  120. Varma M.V.S. Kaushal A.M. Garg A. Garg S. Factors affecting mechanism and kinetics of drug release from matrix-based oral controlled drug delivery systems. Am. J. Drug Deliv. 2004 2 1 43 57 10.2165/00137696‑200402010‑00003
    [Google Scholar]
  121. Serrano D.R. Kara A. Yuste I. 3D printing technologies in personalized medicine, nanomedicines, and biopharmaceuticals. Pharmaceutics 2023 15 2 313 10.3390/pharmaceutics15020313 36839636
    [Google Scholar]
  122. Attar M. Lee V.H.L. Pharmacogenomic considerations in drug delivery. Pharmacogenomics 2003 4 4 443 461 10.1517/phgs.4.4.443.22749 12831323
    [Google Scholar]
  123. Tan Y.J.N. Yong W.P. Kochhar J.S. On-demand fully customizable drug tablets via 3D printing technology for personalized medicine. J. Control. Release 2020 322 42 52 10.1016/j.jconrel.2020.02.046 32145267
    [Google Scholar]
  124. Shukla S.K. Shukla S.K. Govender P.P. Giri N.G. Biodegradable polymeric nanostructures in therapeutic applications: Opportunities and challenges. RSC Advances 2016 6 97 94325 94351 10.1039/C6RA15764E
    [Google Scholar]
  125. Dhar S. Ahmad F. Deshpande A. Rana S.S. Ahmed A.T. Priyadarsini S. 3-Dimensional printing and bioprinting in neurological sciences: Applications in surgery, imaging, tissue engineering, and pharmacology and therapeutics. J. Mater. Sci. Mater. Med. 2025 36 1 32 10.1007/s10856‑025‑06877‑4 40205004
    [Google Scholar]
  126. Narala S. Ali Youssef A.A. Munnangi S.R. 3D printing in vaginal drug delivery: A revolution in pharmaceutical manufacturing. Expert Opin. Drug Deliv. 2024 21 11 1543 1557 10.1080/17425247.2024.2306139 38236621
    [Google Scholar]
  127. Dubey A. Vahabi H. Kumaravel V. Antimicrobial and biodegradable 3D printed scaffolds for orthopedic infections. ACS Biomater. Sci. Eng. 2023 9 7 4020 4044 10.1021/acsbiomaterials.3c00115 37339247
    [Google Scholar]
  128. Hess-Dunning A. Tyler D. A mechanically-adaptive polymer nanocomposite-based intracortical probe and package for chronic neural recording. Micromachines 2018 9 11 583 10.3390/mi9110583 30413034
    [Google Scholar]
  129. Du Z. Cao G. Li K. Zhang R. Li X. Nanocomposites for the delivery of bioactive molecules in tissue repair: Vital structural features, application mechanisms, updated progress and future perspectives. J. Mater. Chem. B Mater. Biol. Med. 2020 8 45 10271 10289 10.1039/D0TB01670E 33084730
    [Google Scholar]
  130. Gharat S.A. Momin M.M. Khan T. Pharmacokinetics and Pharmacodynamics of Novel Drug Delivery Systems: From Basic Concepts to Applications: A Machine-Generated Literature Overview. Singapore Springer 2024 10.1007/978‑981‑99‑7858‑8
    [Google Scholar]
  131. Pandey M. Choudhury H. Fern J.L.C. 3D printing for oral drug delivery: A new tool to customize drug delivery. Drug Deliv. Transl. Res. 2020 10 4 986 1001 10.1007/s13346‑020‑00737‑0 32207070
    [Google Scholar]
  132. Villegas-Ch W García-Ortiz J Sánchez-Viteri S Toward intelligent monitoring in IoT: AI applications for real-time analysis and prediction IEEE Access 2024 12 40368 40386 10.1109/ACCESS.2024.3376707
    [Google Scholar]
  133. Jariwala N. Putta C.L. Gatade K. Intriguing of pharmaceutical product development processes with the help of artificial intelligence and deep/machine learning or artificial neural network. J. Drug Deliv. Sci. Technol. 2023 87 104751 10.1016/j.jddst.2023.104751
    [Google Scholar]
  134. Heikamp K. Bajorath J. Support vector machines for drug discovery. Expert Opin. Drug Discov. 2014 9 1 93 104 10.1517/17460441.2014.866943 24304044
    [Google Scholar]
  135. Kakooee R. Dillenburger B. Reimagining space layout design through deep reinforcement learning. J. Comput. Eng. 2024 11 3 43 55
    [Google Scholar]
  136. Ng W.L. Goh G.L. Goh G.D. Ten J.S.J. Yeong W.Y. Progress and opportunities for machine learning in materials and processes of additive manufacturing. Adv. Mater. 2024 36 34 2310006 10.1002/adma.202310006 38456831
    [Google Scholar]
  137. Allen L.V. Dosage form design and development. Clin. Ther. 2008 30 11 2102 2111 10.1016/j.clinthera.2008.11.015 19108798
    [Google Scholar]
  138. Tsigelny I.F. Artificial intelligence in drug combination therapy. Brief. Bioinform. 2019 20 4 1434 1448 10.1093/bib/bby004 29438494
    [Google Scholar]
  139. Das S.S. Bharadwaj P. Bilal M. Stimuli-responsive polymeric nanocarriers for drug delivery, imaging, and theragnosis. Polymers 2020 12 6 1397 10.3390/polym12061397 32580366
    [Google Scholar]
  140. Trucillo P. Drug carriers: A review on the most used mathematical models for drug release. Processes 2022 10 6 1094 10.3390/pr10061094
    [Google Scholar]
  141. Velasco-Hogan A. Xu J. Meyers M.A. Additive manufacturing as a method to design and optimize bioinspired structures. Adv. Mater. 2018 30 52 1800940 10.1002/adma.201800940 30133816
    [Google Scholar]
  142. Yudaev P. Tupikov A. Chistyakov E. Organocyclophosphazenes and materials based on them for pharmaceuticals and biomedicine. Biomolecules 2025 15 2 262 10.3390/biom15020262 40001565
    [Google Scholar]
  143. Smagina V. Yudaev P. Kuskov A. Chistyakov E. Polymeric gel systems cytotoxicity and drug release as key features for their effective application in various fields of addressed pharmaceuticals delivery. Pharmaceutics 2023 15 3 830 10.3390/pharmaceutics15030830 36986691
    [Google Scholar]
  144. Guo Y. Baldelli A. Singh A. Fathordoobady F. Kitts D. Pratap-Singh A. Production of high loading insulin nanoparticles suitable for oral delivery by spray drying and freeze drying techniques. Sci. Rep. 2022 12 1 9949 10.1038/s41598‑022‑13092‑6 35705561
    [Google Scholar]
  145. Ma P. Huang J. Liu J. Nanoformulation of paclitaxel: Exploring the cyclodextrin/PLGA nano delivery carrier to slow down paclitaxel release, enhance accumulation in vivo. J. Cancer 2023 14 5 759 769 10.7150/jca.82410 37056390
    [Google Scholar]
  146. Pramual S. Lirdprapamongkol K. Atjanasuppat K. Chaisuriya P. Niamsiri N. Svasti J. PLGA-lipid hybrid nanoparticles for overcoming paclitaxel tolerance in anoikis-resistant lung cancer cells. Molecules 2022 27 23 8295 10.3390/molecules27238295 36500387
    [Google Scholar]
  147. Khaledian M. Nourbakhsh M.S. Saber R. Hashemzadeh H. Darvishi M.H. Preparation and evaluation of doxorubicin-loaded pla–peg–fa copolymer containing superparamagnetic iron oxide nanoparticles (Spions) for cancer treatment: Combination therapy with hyperthermia and chemotherapy. Int. J. Nanomedicine 2020 15 6167 6182 10.2147/IJN.S261638 32922000
    [Google Scholar]
  148. Fahmi A. Abdur-Rahman M. Mahareek O. shemis MA. Synthesis, characterization, and cytotoxicity of doxorubicin-loaded polycaprolactone nanocapsules as controlled anti-hepatocellular carcinoma drug release system. BMC Chem. 2022 16 1 95 10.1186/s13065‑022‑00888‑w 36371274
    [Google Scholar]
  149. Ibarra J. Encinas-Basurto D. Almada M. Gold half-shell-coated paclitaxel-loaded PLGA nanoparticles for the targeted chemo-photothermal treatment of cancer. Micromachines 2023 14 7 1390 10.3390/mi14071390 37512701
    [Google Scholar]
  150. Gupta A. Niveria K. Chandpa H.H. Stimuli-responsive magnetic silica-poly-lactic-co-glycolic acid hybrid nanoparticles for targeted cancer chemo-immunotherapy. Drug Deliv. Transl. Res. 2024 14 10 2712 2726 10.1007/s13346‑024‑01521‑0 38347431
    [Google Scholar]
  151. Lin Z. Chou W.C. Cheng Y.H. He C. Monteiro-Riviere N.A. Riviere J.E. Predicting nanoparticle delivery to tumors using machine learning and artificial intelligence approaches. Int. J. Nanomedicine 2022 17 1365 1379 10.2147/IJN.S344208 35360005
    [Google Scholar]
  152. Zhang H. Jackson J.K. Chiao M. Microfabricated drug delivery devices: Design, fabrication, and applications. Adv. Funct. Mater. 2017 27 45 1703606 10.1002/adfm.201703606
    [Google Scholar]
  153. Vettoretti M. Cappon G. Facchinetti A. Sparacino G. Advanced diabetes management using artificial intelligence and continuous glucose monitoring sensors. Sensors 2020 20 14 3870 10.3390/s20143870 32664432
    [Google Scholar]
  154. Tay J.H. Wearable and functional microneedle skin patch platforms with 3D printing for transdermal drug delivery. CCEB Theses 2022
    [Google Scholar]
  155. Bazi Alahri M. Jibril Ibrahim A. Barani M. Management of brain cancer and neurodegenerative disorders with polymer-based nanoparticles as a biocompatible platform. Molecules 2023 28 2 841 10.3390/molecules28020841 36677899
    [Google Scholar]
  156. Makadia H.K. Siegel S.J. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers 2011 3 3 1377 1397 10.3390/polym3031377 22577513
    [Google Scholar]
  157. Illimoottil M. Ginat D. Recent advances in deep learning and medical imaging for head and neck cancer treatment: MRI, CT, and PET scans. Cancers 2023 15 13 3267 10.3390/cancers15133267 37444376
    [Google Scholar]
  158. Cadena M. Ning L. King A. 3D bioprinting of neural tissues. Adv. Healthc. Mater. 2021 10 15 2001600 10.1002/adhm.202001600 33200587
    [Google Scholar]
  159. Warangkar S.C. Deshpande M.R. Totewad N.D. Singh A.A. Antibacterial, antifungal and antiviral nanocomposites: Recent advances and mechanisms of action. Biocomposites-Recent Advances. IntechOpen 2022 10.5772/intechopen.108994
    [Google Scholar]
  160. Srivastava V. Kumar R. Wani M.Y. Robinson K. Ahmad A. Role of artificial intelligence in early diagnosis and treatment of infectious diseases. Infect Dis 2025 57 1 1 26 10.1080/23744235.2024.2425712 39540872
    [Google Scholar]
  161. Erkoc P. Ulucan-Karnak F. Nanotechnology-based antimicrobial and antiviral surface coating strategies. Prosthesis 2021 3 1 25 52 10.3390/prosthesis3010005
    [Google Scholar]
  162. Pala R. Anju V.T. Dyavaiah M. Busi S. Nauli S.M. Nanoparticle-mediated drug delivery for the treatment of cardiovascular diseases. Int. J. Nanomedicine 2020 15 3741 3769 10.2147/IJN.S250872 32547026
    [Google Scholar]
  163. El-Boubbou K. Magnetic glyco-nanoparticles: A new tool to detect bacteria, cancer and atherosclerosis. Electronic Theses & Dissertations 2010
    [Google Scholar]
  164. Gharleghi R. Dessalles C.A. Lal R. 3D printing for cardiovascular applications: From end-to-end processes to emerging developments. Ann. Biomed. Eng. 2021 49 7 1598 1618 10.1007/s10439‑021‑02784‑1 34002286
    [Google Scholar]
  165. Bax M. Thorpe J. Romanov V. The future of personalized cardiovascular medicine demands 3D and 4D printing, stem cells, and artificial intelligence. Front. Sens. 2023 4 1294721 10.3389/fsens.2023.1294721
    [Google Scholar]
  166. Khafaji M. Bavi O. Zamani M. Gold-based hybrid nanostructures: More than just a pretty face for combinational cancer therapy. Biophys. Rev. 2022 14 1 317 326 10.1007/s12551‑021‑00926‑2 35340616
    [Google Scholar]
  167. Khafaji M. Bavi O. Vossoughi M. Plasmomagnetic hybrid gold nanostructures as multifunctional nanocarriers for drug delivery, MRI contrast, and photothermal therapy of drug-resistant cancer cells. J. Drug Deliv. Sci. Technol. 2024 101 106289 10.1016/j.jddst.2024.106289
    [Google Scholar]
  168. Low M.L. Mai C-W. Yeap S.P. Then Y.Y. Rajagopal M.S. Tayyab S. Advances in metal-based compounds as emerging therapeutics for cancer treatment. In: Interdisciplinary Cancer Research. Cham Springer 2024 1 26 10.1007/16833_2024_225
    [Google Scholar]
  169. Chehelgerdi M. Chehelgerdi M. Allela O.Q.B. Progressing nanotechnology to improve targeted cancer treatment: Overcoming hurdles in its clinical implementation. Mol. Cancer 2023 22 1 169 10.1186/s12943‑023‑01865‑0 37814270
    [Google Scholar]
  170. Mousavi S.M. Yari Kalashgrani M. Rahmanian V. Barangizi H. Mahmoudi Z. Sattarpanah Karganroudi S. 3D printing-based polymer nanocomposites for cancer treatment: Innovations and perspectives. Chem. Rec. 2025 25 10 e202500120 10.1002/tcr.202500120 40968502
    [Google Scholar]
  171. Zhang L. Zhou L. Ren L. Laili Y. Modeling and simulation in intelligent manufacturing. Comput. Ind. 2019 112 103123 10.1016/j.compind.2019.08.004
    [Google Scholar]
  172. Moohan J. Stewart S.A. Espinosa E. Cellulose nanofibers and other biopolymers for biomedical applications. A review. Appl. Sci. 2019 10 1 65 10.3390/app10010065
    [Google Scholar]
  173. Mazumdar H. Khondakar K.R. Das S. Halder A. Kaushik A. Artificial intelligence for personalized nanomedicine; from material selection to patient outcomes. Expert Opin. Drug Deliv. 2025 22 1 85 108 10.1080/17425247.2024.2440618 39645588
    [Google Scholar]
  174. Thakur A. Anadebe V.C. Dagdag O. Sharma D. Om H. Fundamentals and recent applications of 3D, 4D, and 5D printing of polymer and its nanocomposites: Challenges and its future prospects. Polymer Nanocomposites for 3D, 4D and 5D Printing. Singapore Springer 2025 345 392 10.1007/978‑981‑96‑4214‑4_14
    [Google Scholar]
  175. Alzoubi L. Aljabali A.A.A. Tambuwala M.M. Empowering precision medicine: The impact of 3D printing on personalized therapeutic. AAPS PharmSciTech 2023 24 8 228 10.1208/s12249‑023‑02682‑w 37964180
    [Google Scholar]
  176. Nazer L.H. Zatarah R. Waldrip S. Bias in artificial intelligence algorithms and recommendations for mitigation. PLOS Digit. Health 2023 2 6 e0000278 10.1371/journal.pdig.0000278 37347721
    [Google Scholar]
  177. Kassa F.M. Youssef S.H. Song Y. Garg S. Use of computational intelligence in customizing drug release from 3D-printed products: A comprehensive review. Pharmaceutics 2025 17 5 551 10.3390/pharmaceutics17050551 40430844
    [Google Scholar]
  178. Tirumala M.G. Anchi P. Raja S. Rachamalla M. Godugu C. Novel methods and approaches for safety evaluation of nanoparticle formulations: A focus towards in vitro models and adverse outcome pathways. Front. Pharmacol. 2021 12 612659 10.3389/fphar.2021.612659 34566630
    [Google Scholar]
  179. Ishaque P.I. Aslam A. Ali M.R. Convergence at the nanoscale: Transformative advances in drug delivery, vaccinology, and biomedical diagnostics. Sch Acad J Pharm 2025 14 6 128 162 10.36347/sajp.2025.v14i06.004
    [Google Scholar]
/content/journals/cdt/10.2174/0113894501430905251210054617
Loading
Personalized Nanocomposite-based Drug Delivery Systems: Integration of AI and 3D Printing
Bentham Science Publishers ; https://doi.org/10.2174/0113894501430905251210054617
/content/journals/cdt/10.2174/0113894501430905251210054617
/content/journals/cdt/10.2174/0113894501430905251210054617
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: 3D printing ; Personalized drug delivery ; artificial intelligence (AI) ; polymeric nanocomposites ; smart drug delivery ; additive manufacturing ; precision medicine

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test